| DC34858 |
endo-BCN-PEG3-Boc-amine |
endo-BCN-PEG3-Boc-amine is a PEG derivative containing a BCN group and a Boc-protected amine. The BCN group can react with azide-tagged biomolecules. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34859 |
bis-PEG2-endo-BCN |
bis-PEG2-endo-BCN is a PEG derivative containing two BCN groups. The BCN group can react with azide-tagged biomolecules. PEG Linkers and PEG derivatives may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34860 |
Boc-Gly-PEG3-endo-BCN |
Boc-Gly-PEG3-endo-BCN is a PEG derivative. PEG Linkers and PEG derivatives may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34861 |
exo-BCN-PEG2-Boc-amine |
exo-BCN-PEG2-Boc-amine is a PEG derivative containing a BCN group and a Boc-protected amine. The protected amine can be deprotected under mild acidic conditions. The BCN group can react with azide-tagged biomolecules. PEG Linkers and PEG derivatives may be useful in the development of antibody drug conjugates. |
|
| DC34862 |
Hydroxy-Amino-bis(PEG2-propargyl) |
Hydroxy-Amino-bis(PEG2-propargyl) is a symmetrical branched alkyne PEG Linker. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34863 |
N-(Acid-PEG2)-N-bis(PEG2-propargyl) |
N-(Acid-PEG2)-N-bis(PEG2-propargyl) is a branched alkyne PEG Linker. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34864 |
N-(Propargyl-PEG2)-N-bis(PEG1-alcohol) |
N-(Propargyl-PEG2)-N-bis(PEG1-alcohol) is a branched alkyne PEG Linker. The alcohol groups can be replaced with other groups via addition reactions. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34865 |
N-(Propargyl-PEG4)-N-bis(PEG4-acid) HCl |
N-(Propargyl-PEG4)-N-bis(PEG4-acid) HCl salt is a branched alkyne PEG Linker. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34866 |
N-(Amino-PEG1)-N-bis(PEG2-propargyl) HCl |
N-(Amino-PEG1)-N-bis(PEG2-propargyl) HCl salt is a PEG derivative containing an amino group with two propargyl groups. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The propargyl groups can be reacted with azide-bearing compounds or biomolecules via copper catalyzed azide-alkyne Click Chemistry to yield a stable triazole linkage. PEG Linkers may be useful in the development of antibody drug conjugates. |
|
| DC34867 |
NH-bis(PEG2-propargyl) |
NH-bis(PEG2-propargyl) is a branched PEG Linker. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34868 |
N-Boc-N-bis(PEG2-propargyl) |
N-Boc-N-bis(PEG2-propargyl) is a branched PEG Linker. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34869 |
N-(Boc-PEG1)-N-bis(PEG2-propargyl) |
N-(Boc-PEG1)-N-bis(PEG2-propargyl) is a branched alkyne PEG Linker. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34870 |
N-(Aminooxy-PEG2)-N-bis(PEG3-propargyl) |
N-(Aminooxy-PEG2)-N-bis(PEG3-propargyl) is a branched alkyne PEG Linker. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34871 |
N-(t-Boc-Aminooxy-PEG2)-N-bis(PEG3-propargyl) |
N-(t-Boc-Aminooxy-PEG2)-N-bis(PEG3-propargyl) is a branched alkyne PEG Linker. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34872 |
N-(t-butyl ester-PEG2)-N-bis(PEG2-propargyl) |
N-(t-butyl ester-PEG2)-N-bis(PEG2-propargyl) is a branched alkyne PEG Linker. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34873 |
N-(Propargyl-PEG2)-N-Boc-PEG3-t-butyl ester |
N-(Propargyl-PEG2)-N-Boc-PEG3-t-butyl ester is a branched alkyne PEG Linker. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34874 |
N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) |
N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) is a branched alkyne PEG Linker. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34875 |
Amino-PEG1-acid |
Amino-PEG1-acid is a PEG derivative containing an amino group with a terminal carboxylic acid. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. PEG Linkers may be useful in the development of antibody drug conjugates. |
|
| DC34876 |
Amino-PEG10-acid |
Amino-PEG10-acidis a PEG derivative containing an amino group with a terminal carboxylic acid. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34877 |
Amino-PEG12-acid |
Amino-PEG12-acid is a PEG derivative containing an amino group with a terminal carboxylic acid. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34878 |
Amino-PEG14-acid |
Amino-PEG14-acid is a PEG derivative containing an amino group with a terminal carboxylic acid. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34879 |
Amino-PEG16-acid |
Amino-PEG16-acid is a PEG derivative containing an amino group with a terminal carboxylic acid. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. PEG Linkers may be useful in the development of antibody drug conjugates. |
|
| DC34880 |
Amino-PEG20-acid |
Amino-PEG20-acid is a PEG derivative containing an amino group with a terminal carboxylic acid. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. |
|
| DC34881 |
Amino-PEG23-acid |
Amino-PEG23-acid is a PEG derivative containing an amino group with a terminal carboxylic acid. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. PEG Linkers may be useful in the development of antibody drug conjugates. |
|
| DC34882 |
Amino-PEG24-acid |
Amino-PEG24-acid is a PEG derivative containing an amino group with a terminal carboxylic acid. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. |
|
| DC34883 |
Amino-PEG25-acid |
Amino-PEG25-acid is a PEG derivative containing an amino group with a terminal carboxylic acid. The amine group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34884 |
Amino-PEG28-acid |
Amino-PEG28-acid is a PEG derivative containing an amino group with a terminal carboxylic acid. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34885 |
Amino-PEG32-acid |
Amino-PEG32-acid is a PEG derivative containing an amino group with a terminal carboxylic acid. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. |
|
| DC34886 |
Amino-PEG36-acid |
Amino-PEG36-acid is a PEG derivative containing an amino group with a terminal carboxylic acid. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. PEG Linkers may be useful in the the development of antibody drug conjugates. |
|
| DC34887 |
Amino-PEG2-CH2CO2H |
Amino-PEG2-CH2CO2H is a PEG derivative containing an amino group with a terminal carboxylic acid. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. PEG Linkers may be useful in the development of antibody drug conjugates. |
|
